Specialty Pharmacy

Popularity of new treatments lead to shrinking demand for Merck's Victrelis.

Pathway discovered that allows aggressive tumors to proliferate.

Protective effect less clear for cutaneous melanoma.

The Center for Pharmacy Practice Accreditation today announced the launch of a new accreditation program for specialty pharmacy practices. The application for accreditation and the newly approved specialty pharmacy accreditation standards are available at http://pharmacypracticeaccredit.org/.

Exclusive interviews with keynote speaker Lunden and program chairman Patrick I. Borgen, MD, of Maimonides Medical Center in Brooklyn, NY, outline cutting edge treatments for patients.

Stem cell transplantation associated with improvements in disability measures and quality of life.

High level of need cited among 9.5 million active and retired servicemen and their families.

Decrease attributed to less toxic therapies and risk reduction measures.

The FDA today approved Novartis' secukinumab (Cosentyx), an interleukin-17A antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

Hospira has received 510(k) regulatory clearance from the FDA for its Plum 360 medication infusion system with Hospira MedNet safety software.

Process may reduce bowel obstructions and surgeries.

Although teixobactin is ineffective against most gram-negative organisms, its potent activity against gram-positive organisms, including vancomycin-resistant enterococci, may help delay the postantibiotic era by decades.

A new FDA-approved drug will provide a new treatment option for adult and pediatric patients undergoing continuous renal replacement therapy.

Raulo Frear, PharmD, general manager of OmedaRx, discusses methods to enhance management of drug utilization programs.

Study warns there is no testing to support a net clinical benefit.

Study finds lack of adherence to sun protection recommendations.

A new study on the effects of cancer patients' financial burdens suggests that pharmacists can play a role in easing or preventing some of their stress.

Discovery may provide hope for treatment of most common form of brain cancer.

In May 2014, the Centers for Disease Control published a guideline document to help pharmacists and other health care professionals avoid common pitfalls of vaccine cold-temperature storage that may affect the efficacy and safety of vaccines.

United States devoting less resources to pharmaceutical industry.

Walgreens official discusses programs and techniques for improving patient adherence.

Chemoradiotherapy regimen before surgery found to be effective in patients with localized rectal cancer.

Pharmacy Times, the pharmacy industry's number 1 journal and the most read publication among pharmacists and pharmacy professionals, and its sister publication, Specialty Pharmacy Times, continue to expand their Strategic Alliance Partnership programs by adding new member organizations.

Thirty-eight of 40 hepatitis C patients treated with 3-drug combination cured in a recent trial.

Sunitinib found to provide unprecedented antitumor activity in treatment of thymic carcinoma.

The National Governors Association is exploring and supporting pharmacists' expanding role in providing direct patient care outside of dispensing medications.

Price Chopper Supermarkets is pleased to announce the launch of its new specialty pharmacy program, which expands pharmacy services in an effort to provide more convenient and personalized solutions for patients living with chronic and complex health conditions. This program is part of a partnership with Aureus Health Services, a specialty pharmacy and health management company.

CVS and Prime Therapeutics agreements follow Express Scripts in hepatitis C formulary updates.

The British National Health Service announced yesterday that it will drop 16 cancer drugs from the list of treatments funded through its Cancer Drugs Fund.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses developments in contracting that specialty pharmacies need to be aware of.